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Abstract
During a comparison of the infectivity of mNDK, a CD4-independent human immunodeficiency virus type 1 (HIV-1) strain, to
various cell lines, we found that HeLa cells were much less susceptible than 293T and TE671 cells. Hybridoma cells between
HeLa and 293T cells were as susceptible as 293T cells, suggesting that cellular factors enhance the mNDK infection in 293T
cells. By screening a cDNA expression library in HeLa cells, cystatin C was isolated as an enhancer of the mNDK infection.
Because cathepsin B protease, a natural ligand of cystatin C, was upregulated in HeLa cells, we speculated that the high
levels of cathepsin B activities were inhibitory to the CD4-independent infection and that cystatin C enhanced the infection
by impairing the excessive cathepsin B activity. Consistent with this idea, pretreatment of HeLa cells with 125 mM of CA-
074Me, a cathepsin B inhibitor, resulted in an 8-fold enhancement of the mNDK infectivity. Because cathepsin B is activated
by low pH in acidic endosomes, we further examined the potential roles of endosomes in the CD4-independent infection.
Suppression of endosome acidification or endocytosis by inhibitors or by an Eps15 dominant negative mutant reduced the
infectivity of mNDK in which CD4-dependent infections were not significantly impaired. Taken together, these results
suggest that endocytosis, endosomal acidification, and cathepsin B activity are involved in the CD4-independent entry of
HIV-1.
Citation: Yoshii H, Kamiyama H, Goto K, Oishi K, Katunuma N, et al. (2011) CD4-Independent Human Immunodeficiency Virus Infection Involves Participation of
Endocytosis and Cathepsin B. PLoS ONE 6(4): e19352. doi:10.1371/journal.pone.0019352
Editor: Jialin Charles Zheng, University of Nebraska Medical Center, United States of America
Received September 2, 2010; Accepted April 4, 2011; Published April 25, 2011
Copyright:  2011 Yoshii et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by NEKKEN Research Grant of Nagasaki University, and by a grant-in-aid from the Japan Society for the Promotion of Science.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: yoshinao@nagasaki-u.ac.jp
¤a Current address: Laboratory of Infectious Diseases, Department of Microbiology and Immunology, Clinical Research Center, National Hospital Organization
Nagoya Medical Center, Aichi, Japan
¤b Current address: Department of Microbiology, National University of Singapore, Singapore
Introduction
Human immunodeficiency virus type 1 (HIV-1) gains entry into host
cells by fusion of the viral envelope membrane with the host cell
membrane. This process is generally initiated by binding of the HIV-1
envelope glycoprotein gp120 to CD4 on the host cell surface. The
binding then induces conformational changes of the gp120, which
allows the gp120 to interact with a cellular surface chemokine receptor,
termed coreceptor [1]. HIV-1 can use many types of chemokine
receptors as the coreceptors [2], but the two most common types of
coreceptors for HIV-1 entry are CXCR4 and CCR5.
HIV-1 variants that do not require CD4 for infection have been
isolated in vitro [3,4,5] and in vivo [6,7]. Gp120 coreceptor binding
sites of CD4-independent HIV-1 variants are exposed before the
CD4 binding, and the CD4-independent gp120 directly interacts
withthecoreceptorfor the entry [5].It has beenreported that CD4-
negative cells such as liver, kidney, and CD8+ T cells are infected
withtheCD4-independentHIV-1inAIDSpatients,andsuchCD4-
independent variants are thought to be associated with hepatitis,
nephropathy, and CD8+ T cell dysfunction in AIDS patients
[6,8,9,10]. Almost all simple retroviruses, including murine
leukemia viruses (MLVs), recognize multiple membrane-spanning
proteins as the HIV-1 coreceptors. CD4-independent variants of
simian immunodeficiency virus have been isolated more frequently
than CD4-independent HIV-1 [11,12]. HIV-1 variants that
recognize CD4 as a sole receptor have not been isolated. These
results suggest that CD4-independent HIV-1 variants are proto-
types of CD4-dependent strains.
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retroviruses, including MLV, avian leukosis virus, Jaagsiekte sheep
retrovirus, equine infectious anemia virus, and foamy virus
[13,14,15,16,17,18,19,20]. It has recently been reported that
inhibitors of endosomal cathepsin proteases attenuate ecotropic
MLV infection[19,20]. These results indicatethat the entry of these
retroviruses occurs through acidic late endosomes and requires
endosomal cathepsin proteases, such as Ebola virus, reovirus,
Japanese encephalitis virus, and coronavirus [21,22,23,24]. Because
cathepsin proteases are activated by low pH in acidic endosomes,
the endosome acidification inhibitors might attenuate the virus
infections by suppressing cathepsin protease activation. However,
the endosome acidification inhibitors do not suppress CD4-
dependent HIV-1 infections, but rather enhance them [25].
Therefore, the CD4-dependent HIV-1 entry likely occurs at the
host cell surface, but not through endosomes. However, it has
recently been shown that CD4-dependent HIV-1 enters into host
cells via endosomes [26,27]. Due to these conflicting observations, it
is unclear whether the CD4-dependent HIV-1 entry occurs through
endosomes or through direct fusion at the cell surface membrane.
The CD4-independent mNDK HIV-1 strain was isolated by
adaptation of the parental CD4-dependent CXCR4-tropic NDK
virus to CD4-negative cells [4]. The CD4-independent mNDK
variant can infect and induce syncytia in CD4-negative CXCR4-
positive cells. However, the mNDK virus more efficiently infects
CD4-positive cells than CD4-negative cells, suggesting that the
mNDK virus induces CD4-independent and -dependent infections
in CD4-negative and -positive cells, respectively [28].
In the present study, we found that HeLa cells are much less
susceptible to infection by an HIV-1 vector having the mNDK
virus envelope protein (Env) than 293T cells. Hybridoma cells
between HeLa and 293T cells were as susceptible to the mNDK
vector infection as 293T cells, indicating that HeLa cells lack a
cellular factor(s) required for the CD4-independent mNDK vector
infection. We aimed to identify the cellular factor by screening of a
cDNA expression library prepared from human lymph nodes.
Cystatin C, which inhibits cystein cathepsin proteases, was isolated
as an enhancer of the CD4-independent mNDK vector infection
in HeLa cells. A synthetic cathepsin B inhibitor, CA-074Me, also
enhanced the CD4-independent mNDK vector infection in HeLa
cells, but did not affect the CD4-dependent infection. These results
show that cathepsin B inhibits the CD4-independent HIV-1 vector
infection. Because cathepsin proteases are activated by low pH in
acidic late endosomes, the CD4-independent mNDK infection
might occur through endosomes. Inhibitors of endosome acidifi-
cation or endocytosis significantly attenuated the CD4-indepen-
dent HIV-1 vector infection, but not the CD4-dependent
infection, as expected. These results suggest that the CD4-
independent HIV-1 enters through acidic late endosomes but
the CD4-dependent HIV-1 does not.
Results
HeLa cells are much less susceptible to CD4-independent
mNDK HIV-1 vector infection than 293T cells
To assess the susceptibility of 293T, TE671, and HeLa cells to an
HIV-1 vector containing the CD4-independent mNDK Env
protein, transduction titers of the HIV-1 vector were measured in
these cells. Transduction titers of the VSV-G- and mNDK Env-
bearing HIV-1 vectors in TE671 cells were about 50% and 30% of
those in 293T cells, respectively (Fig. 1A, left panel). When
normalized by the titer of VSV vector, susceptibility of TE671 cells
to the CD4-independent mNDK vector infection was about 60% of
that in 293T cells. Transduction titers of the VSV and mNDK
vectors in HeLa cells were about 70% and 3% of those in 293T
cells, respectively. Normalization by the titer of VSV vector
indicated that the susceptibility of HeLa cells to the CD4-
independent mNDK vector infection was only about 4% of that
in 293T cells. However, when these cells were engineered to express
CD4, HeLa/CD4 cells were found to be as susceptible to the CD4-
dependent mNDK vector infection as 293T/CD4 and TE671/
CD4 cells (Fig. 1A, right panel). Because CXCR4 is the infection
receptor for the CD4-indepndent infection of the mNDK vector
[4,28], cell surface expressions of CXCR4 in these cells were
analyzed. As the result, HeLa cells expressed CXCR4 more
efficientlythan293T cells(Fig.1B).TheseresultsindicatethatHeLa
cells either possess an inhibitory factor(s) or lack a factor(s) necessary
for the CD4-independent mNDK HIV-1 vector infection.
HeLa cells lack a cellular factor(s) required for CD4-
independent HIV-1 vector infection
To determine whether ‘‘positive’’ or ‘‘negative’’ factors are
involved in the resistant phenotype of HeLa cells, hybridoma cells
between HeLa and 293T cells were constructed. HeLa cells were
inoculated with a puromycin resistance gene-encoding MLV
vector to construct drug-resistant cells. 293T cells are originally
geneticin-resistant. The puromycin-resistant HeLa cells were fused
with the geneticin-resistant 293T cells by polyethylene glycol, and
hybridoma cells were obtained by co-selection with puromycin
and geneticin. The double antibiotics-resistant cell pools were used
for the following study. All four independent hybridoma cell pools
were as susceptible to the CD4-independent mNDK vector
infection as 293T cells (Fig. 1C). This shows that HeLa cells lack
a cellular factor(s) that is required for the CD4-independent
mNDK vector infection.
Identification of cystatin C as a crucial factor for the CD4-
independent mNDK vector infection
To identify the cellular factor required for the CD4-indepen-
dent mNDK vector infection, HeLa cells were transfected with a
cDNA expression library constructed from human lymph nodes,
because it has been reported that human lymph node cells
including CD8+ T-lymphocytes are highly susceptible to CD4-
independent HIV-1 variants [29]. Because the plasmid vector used
in the cDNA library construction contains a neomycin-resistance
gene, the transfected HeLa cells were selected by geneticin. The
geneticin-resistant HeLa cells were inoculated with an mNDK
HIV-1 vector containing a blasticidin-resistance gene as a
selectable marker. The mNDK HIV-1 vector was diluted to
obtain one blasticidin-resistant cell colony in normal HeLa cells
per a 10-cm culture dish. This experiment was repeated seven
times, and finally six blasticidin-resistant cell clones were obtained.
Among these blasticidin-resistant cell clones, one cell clone (HmN-
2) was 4.5 times more susceptible to the LacZ gene-encoding
mNDK HIV-1 vector infection than parental HeLa cells (Fig. 2A).
The susceptibility of the other blasticidin-resistant cell clones was
almost same as that of the original HeLa cells.
To obtain the cDNA fragment expressed in the HmN-2 cells,
PCR was performed using a genomic DNA prepared from the
HmN-2 cells. The PCR primers were complementary to both
flanking regions of the cDNA inserts in the cDNA library plasmid.
As a result, an approximately 0.6-kb PCR fragment was detected
(Fig. 2B), and partial sequencing indicated that it was cystatin C.
The endogenous cystatin C mRNA is about 0.7-kb long, and
encodes a 120-amino acid protein. The cystatin C protein is
abundantly expressed in many tissues, and inhibits cystein protease
activity [30]. Expression of the cystatin C protein in the HmN-2
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cystatin C antibody (Fig. 2C). The cystatin C mRNA was not
detected in HeLa, TE671, and 293T cells (Fig. 2D).
To confirm the role of cystatin C in the CD4-independent mNDK
vector infection, HeLa, HeLa/CD4, TE671, TE671/CD4, 293T,
and293T/CD4cellsstablyexpressingcystatinCwereconstructedby
using an MLV vector encoding cystatin C. HeLa cells expressing
cystatin C were about 3 times more susceptible to the mNDK vector
infection than control HeLa cells transduced by the empty MLV
vector (Fig. 3A, upper panels). Cystatin C expression also enhanced
the CD4-dependent infection, but the effect on the CD4-dependent
infection was less than that on the CD4-independent infection.
Cystatin C protein expression in these transduced cells was confirmed
by Western immunoblotting (Fig. 3A, lower panels). Cystatin C
expression resulted in a 1.5-fold enhancement of the susceptibility of
TE671 cells to the CD4-independent HIV-1 vector infection, but did
not affect the susceptibility of TE671/CD4 cells. Cystatin C
expression did not affect the mNDK vector infection in CD4-
negative and –positive 293T cells. Cystatin C did not affect the cell
surface expression of CXCR4 in HeLa cells (Fig. 3B), indicating that
cystatinCdoesnotincreasetheCD4-independent vectorinfectionby
enhancing CXCR4 expression. Collectively, these findings indicate
that cystatin C enhances the CD4-independent mNDK vector
infection in HeLa and TE671 cells, but does not in 293T cells.
Cellular susceptibility to CD4-independent infection is
reverse-correlated with cathepsin B activity
Next, we quantitatively measured cathepsin B activity in HeLa,
TE671, and 293T cells (see Materials and Methods). The
cathepsin B activities were highest in HeLa cells, followed in
order by TE671 and 293T cells (Figs. 4A and B). The target cells
expressing higher level of cathepsin B activity were less susceptible
to the CD4-independent mNDK vector infection, suggesting that
cathepsin B inhibits the CD4-independent HIV-1 infection.
Cystatin C expression indeed reduced cathepsin B activities in
TE671 and HeLa cells (Fig. 4C). Cystatin C neither inhibited
cathepsin B activity nor enhanced the CD4-independent vector
infection in 293T cells (Fig. 3A), probably because the cathepsin B
activity of 293T cells was originally low.
A synthetic cathepsin B inhibitor enhances susceptibility
to CD4-independent infection
To address whether cystatin C enhances the CD4-independent
HIV-1 vector infection by inhibiting cathepsin protease activity,
the effects of synthetic cathepsin protease inhibitors on CD4-
independent vector infection were analyzed. Target cells were
pretreated with cathepsin inhibitors for 5 h. As expected, when
HeLa cells were treated with a specific cathepsin B inhibitor,
Figure 1. Susceptibility of 293T, TE671, and HeLa cells to CD4-independent mNDK HIV-1 vector infection. (A) Transduction titers of
VSV-G- or mNDK Env protein-pseudotyped HIV-1 vector on 293T, TE671, HeLa, and their CD4-expressing cells were measured. Relative values to the
transduction titer on 293T (left panel) or 293T/CD4 cells (1610
5) (right panel) are indicated. This experiment was repeated 3 times, and the results are
shown as the means +2 SD. Asterisks indicate statistically significant differences compared to the relative value on the control cells. (B) The cell
surface expression of CXCR4 was analyzed on 293T, TE671, and HeLa cells by a fluorescence flow cytometer using an anti-CXCR4 monoclonal
antibody. Closed and open areas indicate cells treated only with the secondary FITC-conjugated anti-rat IgG antibody and cells treated with the
CXCR4 antibody and then with the secondary antibody, respectively. (C) Transduction titers of the mNDK HIV-1 vector on hybridoma cells between
293T and HeLa cells were measured. Relative values to the transduction titer on 293T cells are indicated. This experiment was repeated 3 times, and
the results are shown as the means +2 SD. Asterisks indicate statistically significant differences compared to the relative value on 293T cells.
doi:10.1371/journal.pone.0019352.g001
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vector was increased 8-fold (Fig. 5A). Similarly, CA-074Me
treatment of TE671 cells at 50 mM induced a 5-fold enhancement
of the CD4-independent infection. In association with this change,
cathepsin B activity was indeed reduced by these CA-074Me
treatments in HeLa and TE671 cells to about 50%, a level similar
to that in the control 293T cells (Fig. 4B). These results indicate
that cathepsin B inhibition by cystatin C or CA-074Me leads to
enhancement of the CD4-independent vector infection, suggesting
that cathepsin B plays a role in suppressing the CD4-independent
HIV-1 infection in HeLa and TE671 cells, which express
cathepsin B at a relatively higher level.
In contrast, CA-074Me treatment attenuated the CD4-inde-
pendent vector infection in a dose-dependent manner in 293T
cells (Fig. 5A), whose cathepsin B activity was extremely low
(Figs. 4A and B). The 293T cells were then treated with CA-
074Me at a lower concentration to see whether or not the CD4-
independent vector infection would be promoted. By the CA-
074Me treatment of 293T cells at 2 mM, cathepsin B activity was
only slightly inhibited, to about 85% of that in DMSO-treated
293T cells. But when 293T cells were treated with CA-074Me at a
lower concentration, cathepsin B activity in the treated 293T cells
was not affected and the CD4-independent infection was not
enhanced. The CA-074Me treatment did not affect the CD4-
dependent mNDK vector infection in 293T/CD4 cells.
The cathepsin L specific inhibitor, CLIK148 [31], did not affect
the mNDK vector infection in CD4-negative and –positive cells
(data not shown).
SAOS-2 cells are resistant to the CD4-independent
infection due to high cathepsin B activity
The above results suggest that cathepsin B activity is reverse-
correlated with susceptibility to the CD4-independent mNDK
vector infection in 293T, TE671, and HeLa cells. To further
confirm the result, susceptibility to the CD4-independent infection
and cathepsin B activity of other two cell lines, SAOS-2 and C33A
cells, were measured. Surprisingly, mNDK vector-infected cells
were not detected in SAOS-2 cells (Fig. 6A). Cathepsin B activity
of SAOS-2 cells was higher than that of HeLa cells (Fig. 6B), and
CA-074Me treatment conferred SAOS-2 cells susceptible to the
CD4-independent mNDK vector infection (Fig. 6C), suggesting
that SAOS-2 cells are completely resistant to the CD4-indepen-
dent infection due to the high level of cathepsin B activity.
However, because SAOS-2 cells were less susceptible to the VSV-
G-pseudotyped HIV-1 vector infection than 293T cells (Fig. 6A),
the infection resistance of SAOS-2 cells is likely to involve post-
entry mechanisms either. C33A cells were as susceptible to the
CD4-independent mNDK vector infection as TE671 cells, and
have similar level of cathepsin B activity to TE671 cells (Figs. 6A
and B). CA-074Me treatment of C33A cells at 50 mM enhanced
the CD4-independent infection about 5 times, like TE671 cells
(Fig. 6D). Statistical analysis reveals that susceptibility to the CD4-
independent mNDK vector infection was reverse-correlated with
cathepsin B activity of the target cells (Fig. 6E). These results
strongly support the conclusion that cathepsin B is one of the
critical cellular factors determining susceptibility to the CD4-
independent HIV-1 infection.
Figure 2. Cystatin C was isolated as an enhancer of the CD4-independent mNDK HIV-1 vector infection. (A) A blasticidin resistance
gene-bearing mNDK HIV-1 vector was inoculated into the cDNA expression library-transfected HeLa cells, and blasticidin-resistant cell clones were
isolated. Transduction titers of the LacZ gene-bearing mNDK HIV-1 vector were measured on these blasticidin-resistant cell clones. Relative valuest o
the transduction titer on normal HeLa cells are indicated. This experiment was repeated 3 times, and the results are shown as the means +2 SD.
Asterisks indicate statistically significant differences compared to the relative value on HeLa cells. (B) PCR was performed using genomic DNA samples
prepared from the HmN-2 cells. The PCR products were subjected to agarose gel electrophoresis. (C) A cell lysate prepared from the HmN-2 cells was
analyzed by Western immunoblotting using an anti-cystatin C (upper panel) or anti-actin (lower panel) antibody. (D) To detect cystatin C or GAPDH
mRNA, RT-PCR was performed. The PCR products were subjected to agarose gel electrophoresis.
doi:10.1371/journal.pone.0019352.g002
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independent infection in 293T cells
The above results indicate that cathepsin B inhibits the CD4-
independent mNDK vector infection in cells with high cathepsin B
activity. To confirm that cathepsin B inhibits the CD4-independent
vector infection, the effects of cathepsin B overexpression on the CD4-
independent vector infection were analyzed in 293T cells, in which
cathepsin B is expressed at a low level. 293T cells were inoculated with
an MLV vector encoding cathepsin B and puromycin-resistance genes,
and were selected by puromycin. The puromycin-resistant 293T cell
pool indeed had elevated level of cathepsin B activity compared to the
control 293T cells (Fig. 7A). The cathepsin B overexpression
significantly inhibited the CD4-independent vector infection, but did
not the CD4-dependent infection (Fig. 7B). When the cathepsin B-
overexpressing 293T cells were treated with CA-074Me at 25 mM, the
CD4-independent vector infection was enhanced (Fig. 7C), as in HeLa
and TE671 cells.These results suggest that cathepsin B is a host defense
factor against the CD4-independent infection, but not against the
CD4-dependent infection.
Cathepsin B functions as an innate immune factor
against CD4-independent HIV-1 infection
IthasbeenreportedthatLPStreatmentofcellsenhancescathepsin
B expression [32,33,34]. Therefore, the activation of innate immunity
by LPS-mediated TLR4 signaling might attenuate the CD4-
independent HIV-1 infection. To address this hypothesis, 293T cells
originally expressing cathepsin B at a low level (Fig. 4A) were
transfected by a CD4-TLR4 expression plasmid constructed by our
research group. CD4-TLR4 is a fusion protein of the extracellular
domain of CD4 and the intracellular domain of TLR4, and functions
as a constitutively active mutant of TLR4 [35]. NF- B activation by
the transfection of 293T cells with the CD4-TLR4 expression
plasmid was observed (data not shown). Because the extracellular
domain of CD4-TLR4 was derived from mouse CD4, it should not
directly affect the CD4-independent HIV-1 vector infection [36].
As expected, TLR4 signal activation by CD4-TLR4 reduced the
CD4-independent vector infectionin 293T cells (Fig. 8A, left panel).
The CD4-TLR4 transfection did not affect the CD4-independent
infection in TE671 and HeLa cells, in which cathepsin B was
originally expressed at a high level. The CD4-TLR4 transfection
did not affect the CD4-dependent HIV-1 vector infection in 293T/
CD4 cells (Fig. 8A, right panel). The inhibitory effect of CD4-TLR4
on the CD4-independent infectionwasabrogatedby treatment with
the cathepsin B inhibitor, CA-074Me (10 mM) (Fig. 8B). CD4-
TLR4 plasmid transfection indeed enhanced cathepsin B mRNA
expression as analyzed by RT-PCR (Fig. 8C), and cathepsin B
activity 1.5-fold in 293T cells (Fig. 8D). These results indicate that
the TLR4 signal activation induces cathepsin B expression and
Figure 3. Cystatin C enhances the CD4-independent mNDK HIV-1 vector infection. (A) Transduction titers of the mNDK HIV-1 vector were
measured on cystatin C-transduced and -untransduced HeLa, TE671, 293T, and their CD4-expressing cells. Relative values to the transduction titer on
cystatin C-untransduced cells are indicated (upper panel). This experiment was repeated 3 times, and the results are shown as the means +2 SD.
Asterisks indicate statistically significant differences compared to the relative value on the each cystatin C-untransduced cells. Cystatin C expression
was confirmed by Western immunoblotting using the cystatin C antibody (lower panel). (B) The cell surface expression of CXCR4 on the cystatin C-
transduced and –untransduced HeLa cells was analyzed by a fluorescence flow cytometer. Closed and open areas indicate cells treated with control
serum and then with the secondary FITC-conjugated anti-rat IgG antibody and cells treated with the CXCR4 antibody and then with the secondary
antibody, respectively. Relative values to means of fluorescence intensity in the untransduced cells are also indicated. This experiment was repeated 3
times, and the results are shown as averages +2 SD.
doi:10.1371/journal.pone.0019352.g003
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suggesting that cathepsin B functions as an innate immune factor
against CD4-independent HIV-1 infection.
Endosomal acidification is required for CD4-independent
HIV-1 infection
The above results indicate that cathepsin B attenuates the CD4-
independent mNDK vector infection in cells with high cathepsin B
activity, but does not the CD4-dependent infection. Because
cathepsin B is activated by low pH in acidic endosomes, the
CD4-independent mNDK vector might enter host cells through
acidic endosomes. Because the CD4-dependent HIV-1 does not
enter host cells through acidic endosomes [25], cathepsin B might
have no effect on the CD4-dependent infection. To examine these
possibilities, the effects of endosome acidification inhibitors,
bafilomycin A-1 (BFLA-1) and chloroquine, on the CD4-indepen-
dent and –dependent HIV-1 vector infections were analyzed.
Target cells were pretreated with the inhibitors for 5 h before the
HIV-1 vector inoculation. Treatment of 293T (Fig. 9A), TE671
(Fig. 9B), and HeLa (Fig. 9C) cells with these inhibitors attenuated the
CD4-independent mNDK vector infection in a dose-dependent
manner. In contrast, the CD4-dependent HXB2 (Fig. 9) and mNDK
vector (data not shown) infections were not inhibited by these inhibitors
in CD4-expressing cells, and were actually increased in TE671 and
HeLa cells, as previously reported [25]. Higher concentrations of the
inhibitors were required to inhibit the CD4-independent HIV-1 vector
infection in HeLa cells than in 293T cells, correlating with the levels of
cathepsin B activity in these cells. The chloroquine treatment of cells
reduced cathepsin B activity of cell lysates prepared from the treated
cells (Fig. 9D left panel). However, when chloroquine was added to the
cell lysates, their cathesin B activities were not reduced (Fig. 9D right
panel). Because cathepsin proteases are activated by endosome
acidification, the endosome acidification inhibitor treatment of cells
suppresses cathepsin B activation, but not cathepsin activity.
Treatments with these inhibitors did not reduce the cell surface
expression of CXCR4 (Fig. 9E), indicating that abrogation of the CD4-
independent infection by the endosome acidification inhibitors is not
due to the suppression of CXCR4 expression. These results indicate
that the CD4-independent, but not the CD4-dependent, HIV-1
infection requires endosome acidification and occurs through acidic
late endosomes.
Endocytosis is required for CD4-independent HIV-1
infection
The above results suggest that the CD4-independent HIV-1
particles are internalized by endocytosis for the infection. To
Figure 4. Cathepsin B activity of 293T, TE671, and HeLa cells. (A) Cathepsin B activities in living 293T, TE671, and HeLa cells were analyzed by
the cathepsin B detection reagent. The closed area and green line indicate cells unstained and cells stained with the cathepsin B detection reagent,
respectively. (B) Fluorescence intensities of cell lysates prepared from HeLa, TE671, 293T, and their CA-074Me-treated cells were measured to
quantitate cathepsin B activity by using a cathepsin B activity assay kit. This experiment was repeated 3 times, and the results are shown as the means
+2 SD. Asterisks indicate statistically significant differences compared to the fluorescence intensity on DMSO-treated control cells. (C) CathepsinB
activities of cell lysates prepared from HeLa, TE671, 293T, and their cystatin C-expressing cells were analyzed by using a cathepsin B activity assay kit.
Relative values to the fluorescence intensity for each cell type not expressing cystatin C are indicated. This experiment was repeated 3 times, and the
results are shown as the means +2 SD. Asterisks indicate statistically significant differences compared to the relative value on the cells not expressing
cystatin C.
doi:10.1371/journal.pone.0019352.g004
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or an Eps15 dominant negative mutant (Eps15-DN) [37,38], on the
CD4-independent and -dependent HIV-1 vector infections were
analyzed. Target cells were pretreated with dynasore for 5 h.
Dynasore inhibits dynamine GTPase and clathrin-dependent
endocytosis [39]. Dynasore treatment more efficiently attenuated
the CD4-independent mNDK vector infection than the CD4-
dependent mNDK (Fig. 10A) or HXB2 (data not shown) vector
infection in all examined cells (P,0.05). The dynasore treatment
did not affect the cell surface expression of CXCR4 (Fig. 10B),
demonstrating that dynasore treatment attenuated the CD4-
independent HIV-1 infection through a mechanism other than
the suppression of CXCR4 expression. The dynasore treatment of
target cells moderately attenuated cathepsin B activity (Fig. 10C left
panel). However, when dynasore was added to cell lysates, the
cathepsin B activity was not affected (Fig. 10C right panel).
Inhibition of endocytosis by dynasore might suppress cathepsin B
activity by reducing number of endosomes in the treated cells,
because active cathepsin B is present in late endosomes. The
dynasore treatment inhibited endocytosis of Cy3-conjugated
transferin as expected (Fig. 10D). However, the chloroquine or
CA-074Me treatment did not. This result suggests that the
chloroquineorCA-074MetreatmentinhibitstheCD4-independent
HIV-1 vector infection by a mechanism other than endocytosis
suppression.
Eps15 is involved in endosytosis, and its dominant negative
mutant (Eps15-DN) suppresses endocytosis [37,38]. Because the
Eps15-DN is tagged with GFP, expression of the Eps15-DN in the
transfected cells was analyzed by a flow cytometry. The Eps15-DN
suppressed the CD4-independent mNDK infection, but not the
CD4-dependent infection (Fig. 11A) under conditions that the
levels of Eps15-DN expression in the CD4-negative and –positive
cells were similar (Fig. 11B). In TE671 cells, the Eps15-DN rather
enhanced the CD4-dependent HIV-1 vector infection provably
due to elevated expression of CXCR4 (Fig. 11C). CXCR4
expression in 293T and HeLa cells was not affected by the Eps15-
DN. These results indicate that endocytosis is more profoundly
involved in the CD4-independent HIV-1 infection than the CD4-
dependent infection.
CD4-independent ROD/B vector infection also involves
participation of endocytosis, endosomal acidification,
and cathepsin B activities
The above results indicate that endosome acidification, endocy-
tosis, and cathepsin B activity are involved in the CD4-independent
mNDK Env-mediated infection. To assess whether these cellular
events are also involved in another CD4-independent infection,
HIV-1 vector containing Env protein of the CD4-independent
ROD/B HIV-2 strain [40] was constructed. As seen in the mNDK
Figure 5. Effects of a cathepsin B inhibitor, CA-074Me, on the CD4-independent HIV-1 vector infection. (A) Transduction titers were
measured on CA-074Me- or DMSO-treated 293T, TE671, and HeLa cells. Relative values to the titer on cells treated with an equal volume of DMSO are
indicated. This experiment was repeated 3 times, and the results are shown as the means +2 SD. Asterisks indicate statistically significant differences
compared to the relative value on each type of DMSO-treated cells. (B) The cell surface expression of CXCR4 was analyzed on CA-074Me-treated cells.
Closed and open areas indicate cells treated with the control serum and then with the secondary FITC-conjugated anti-rat IgG antibody and cells
treated with the CXCR4 antibody and then with the secondary antibody, respectively. Relative values to means of fluorescence intensity in the DMSO-
treated cells are also indicated. This experiment was repeated 3 times, and the results are shown as averages +2 SD.
doi:10.1371/journal.pone.0019352.g005
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treatment at 50 mM in CD4-negative TE671 cells (Fig. 12A). The
endosome acdification inhibitor (chloroquine) and endocytosis
inhibitor (dynasore) suppressed the CD4-independent ROD/B
infection, but not the CD4-dependent infection. These results
indicate that endosome acidification, endocytosis, and cathepsin B
activity are involved not only in the CD4-independent mNDK
infection, but also in the CD4-independent ROD/B infection.
Discussion
Inhibition of cathepsin B activity by cystatin C expression or by
the specific inhibitor for cathepsin B, CA-074Me, significantly
enhanced the CD4-independent HIV-1 vector infection in HeLa
and TE671 cells, both of which express cathepsin B at relatively
higher levels. Cathepsin B activity was inversely correlated with
cellular susceptibility to the CD4-independent HIV-1 vector
infection. Overexpression of cathepsin B attenuated the CD4-
independent vector infection in 293T cells. The TLR4 signal
activation also attenuated the CD4-independent vector infection by
enhancing cathepsin B expression. These results indicate that
cathepsin B is one of the host innate immune factors resisting to the
CD4-independent HIV-1 infection. The endocytosis inhibitors,
dynasore and Eps15-DN, suppressed the CD4-independent HIV-1
vector infection, showing that the CD4-independent infection
occurs through endosomes. The mechanism by which cathepsin B
inhibits the CD4-independent infection is suggested as follows;
higher cathepsin B protease activity in SAOS-2, HeLa, and TE671
cells causes degradation of the HIV-1 particles in acidic endosomes,
attenuating the CD4-independent HIV-1 infection (Fig. 13).
Inhibition of cathepsin B by the cystatin C expression or by the
CA-074Me treatment increases the CD4-independent infection by
suppressing the viral particle degradation.
Since cystatin C is not expressed in 293T cells, cystatin C may
not be the factor necessary for the CD4-independent infection in
293T cells. However, because cathepsin B clearly had an
inhibitory effect on the CD4-independent infection and because
cathepsin B activity in 293T cells is extremely low, 293T cells
could have another factor(s) suppressing cathepsin B activity that is
not expressed in HeLa cells. Another cystatin member, cystatin B,
has been reported to be associated with higher susceptibility of
monocyte-derived macrophages to CD4-dependent HIV-1 infec-
tion when compared to placental macrophages [41]. Because
cystatin B is localized predominantly in the cytoplasm, while
cystatin C is generally located in late endosomes [42] or secreted,
and because cystatin C did not affect the CD4-dependent HIV-1
infection in our study, the roles of cystatins B and C in HIV-1
infection should be different.
Endosome acidification inhibitors are also known to attenuate
infections by many other retroviruses, indicating that these
retrovirus infections occur through acidic endosomes [13,14,
15,16,17,18]. In this study, the CD4-independent HIV-1 infection
Figure 6. SAOS-2 cells are resistant to the CD4-independent HIV-1 vector infection. (A) Transduction titers of the mNDK and VSV-G vectors
were measured on 293T, SAOS-2, and C33A cells. Relative values to the titers on 293T cells are indicated. (B) Cathepsin B activities of cell lysates from
293T, HeLa, SAOS-2 and C33A cells were measured by the cathepsin B activity assay kit. (C) Transduction titers of the mNDK vector were measured on
DMSO- (Cont.) or CA-074Me-treated SAOS-2 cells. (D) Transduction titers of the mNDK vector were measured on DMSO- (Cont.) or CA-074Me-treated
C33A cells. These experiments were repeated 3 times, and the results are shown as the means +2 SD. Asterisks indicate statistically significant
differences compared to the control cells. (E) Relative values to the cathepsin B activity of SAOS-2 cells (x axis) and to the transduction titer in 293T
cells (y axis) are plotted. Correlation between cathepsin B activity and susceptibility to the CD4-independent infection was analyzed by Spearman’s
rank correlation.
doi:10.1371/journal.pone.0019352.g006
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DN. This strongly indicates that the CD4-independent HIV-1
infection occurs through acidic endosomes, as in the case of other
retroviruses (Fig. 13). In contrast, the inhibitors less efficiently
attenuated the CD4-dependent HIV-1 vector infection than the
CD4-independent infection, as they did in a previous report [25],
suggesting that the CD4-dependent infection does not occur
through acidic endosomes. However, Miyauchi et al. recently
reported that CD4-dependent HIV-1 enters host cells via
endosomes [26,27]. The CD4-dependent HIV-1 particles might
be internalized by dynamin-independent endocytosis. Even if the
CD4-dependent HIV-1 particles are internalized into endosomes
for productive infection, the CD4-dependent HIV-1 entry might
occur before HIV-1 particle-bearing endosomes become acidic in
late endosomes (Fig. 13). Further studies are needed to clarify this
issue.
The endosome acidification inhibitors are thought to enhance
the CD4-independent HIV-1 vector infection by suppressing
cathepsin B activity, because cathepsin B is activated by low pH in
acidic endosomes. Indeed, the endosome acidification inhibitors
reduced cathepsin B activity. The inhibition of cathepsin B activity
by the CA-074Me treatment enhanced the CD4-independent
HIV-1 vector infection in HeLa and TE671 cells. Because the
endosome acidification inhibitors much less efficiently attenuated
cathepsin B activity than CA-074Me, the endosome acidification
inhibitors could not enhance the CD4-independent infection. This
result suggests that the endosome acidification itself is directly
involved in the CD4-independent HIV-1 entry, as in the case of
influenza virus and VSV [43].
TLR4 signal activation by the CD4-TLR4 attenuated the CD4-
independent HIV-1 vector infection by enhancing cathepsin B
expression, suggesting that cathepsin B functions as an innate
immune factor resisting the CD4-independent HIV-1. Endosomal
cathepsin proteases degrade microbes invading into host cells, and
generate peptide presented on MHC class II in order to protect
the host against the microbes [44]. In this context, it is interesting
that several microbes encode cathepsin protease inhibitors
homologous to the cystatin family [45,46,47]. Such microbial
cystatins inhibit the host innate and adaptive immunity mediated
by cathepsin proteases to allow efficient microbe proliferation in
infected animals. The endocytic infection route of retroviruses
might be changed to a cell surface infection route to escape from
the host immunity mediated by endosomal cathepsin proteases,
instead of having a cathepsin inhibitor.
This study indicates that cathepsin B inhibits CD4-indepen-
dent HIV-1 infection. The CD4-independent HIV-1 infection
occurs through acidic endosomes. The HIV-1 particles could be
degraded predominantly by cathepsin B after the viral particles
are internalized into endosomes, reducing the CD4-independent
infection. Additionally, in this study, it was speculated that the
Figure 7. Cathepsin B attenuates the CD4-independent HIV-1 vector infection. (A) Cathepsin B activities of control and cathepsin B-
overexpressing 293T cells were measured by the cathepsin B detection reagent. The closed area indicates cells not stained with the cathepsin B
detection reagent. The red and green lines indicate the control and cathepsin B-overexpressing 293T cells, respectively. (B) Transduction titers of the
mNDK vector were measured on cathepsin B-untransduced and –transduced 293T and 293T/CD4 cells. Relative values to the titers on the
untransduced 293T and 293T/CD4 cells are indicated. (C) Transduction titers of the mNDK vector were measured on CA-074Me-treated, cathepsin B-
overexpressing 293T cells. Relative values to the titer on DMSO-treated cells are indicated. These experiments were repeated 3 times, and the results
are shown as the means + SD. Asterisks indicate statistically significant differences compared to the relative value on the control cells.
doi:10.1371/journal.pone.0019352.g007
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through acidic endosomes. Even when the CD4-dependent HIV-
1 particles are internalized to endosomes, the viral entry might
occur before the HIV-1 virion-containing endosomes have
become acidic. Comparative studies between CD4-dependent
and –independent HIV-1 infections will pave the way to
clarification of the novel mechanisms that have not been
disclosed using only CD4-dependent HIV-1, as we have already
reported [28,48].
Materials and Methods
Expression plasmids
The CD4-independent HIV Env (mNDK and ROD/B)
expression plasmids were kindly provided by Dr. U. Hazan [4]
and Dr. P. R. Clapham [49]. The CD4-dependent HIV-1 Env
(HXB2 strain) expression plasmid was kindly provided by Dr. Y.
Yokomaku. The VSV-G expression plasmid (pHEF-VSVG) was
obtained from Dr. L. Chang [50] through the AIDS Research and
Reference Reagent Program, Division of AIDS, NIAID, NIH,
USA. An expression plasmid encoding the CD4-TLR4 fusion
protein that is a constitutively active form of the TLR4 was
constructed in our research group as previously reported [35]. An
expression plasmid of the Eps15 dominant negative mutant
[37,38] was provided by Dr. A. Benmerah through Dr. M. J.
Tremblay [51].
Cells
Human HeLa [52], TE671 [53], 293T [54], SAOS-2 [55], and
C33A [56] cells were cultured in Dulbecco’s modified Eagle’s
medium (Wako, Osaka, Japan) at 37uCi n5 %C O 2. The culture
media were supplemented with 8% fetal bovine serum (Biosource,
Rockville, MD). HeLa, TE671, and 293T cells stably expressing
CD4 (HeLa/CD4, TE671/CD4, 293T/CD4) were constructed as
follows. These cells were transfected with an expression plasmid
encoding CD4- and hygromycin-resistance genes (Invitrogen,
Carlsbad, CA), and selected by hygromycin (Invitrogen). Hygro-
mycin-resistant cell clones expressing CD4 were selected by FACS
analysis using a FITC-conjugated anti-CD4 antibody (Sigma, St.
Louis, MO). To construct cystatin C-expressing cells, HeLa,
TE671, 293T, and their CD4-expressing cells were inoculated
with an MLV vector encoding cystatin C (Origene, Rockville,
MD) as previously reported [57]. Because the MLV vector
additionally encodes a puromycin-resistance gene, the inoculated
cells were selected by puromycin (Sigma). Puromycin-resistant cell
pools were used in this study. To construct cathepsin B-
overexpressing cells, 293T and 293T/CD4 cells were inoculated
with a cathepsin B-encoding MLV vector, and selected by
puromycin. The puromycin-resistant cell pools were used in this
study. To construct hybridoma cells between HeLa and 293T
cells, puromycin-resistant HeLa and geneticin-resistant 293T cells
were fused by polyethylene glycol 1500 (Roche, Indianapolis, IN),
and were selected simultaneously by puromycin and geneticin
Figure 8. TLR4 signal activation attenuates the CD4-independent HIV-1 vector infection by enhancing cathepsin B expression. (A)
Transduction titers of the mNDK HIV-1 vector were measured on pcDNA3.1- or CD4-TLR4 expression plasmid-transfected 293T, TE671, HeLa, (left
panel) and 293T/CD4 (right panel) cells. Relative values to the titer on the pcDNA3.1-transfected cells are indicated. (B) Transduction titers of the
mNDK vector were measured on CA-074Me- or DMSO-treated CD4-TLR4-transfected 293T cells. Relative values to the titer on the pcDNA3.1-
transfected 293T cells are shown. These experiments were repeated 3 times, and the results are shown as the means +2 SD. Asterisks indicate
statistically significant differences compared to the relative value on the control cells. (C) Cathepsin B mRNA expression was analyzed by semi-
quantitative RT-PCR. PCR products were subjected to agarose gel electrophoresis. (D) The cathepsin B activity of the pcDNA3.1- or CD4-TLR4
expression plasmid-transfected 293T cells was measured by a cathepsin B activity assay kit. Relative values to the fluorescence intensity on the
pcDNA3.1-transfected cells are indicated. This experiment was repeated 3 times, and the results are shown as the means +2 SD. Asterisks indicate
statistically significant differences compared to the relative value on the pcDNA3.1-transfected cells.
doi:10.1371/journal.pone.0019352.g008
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PLoS ONE | www.plosone.org 10 April 2011 | Volume 6 | Issue 4 | e19352Figure 9. Effects of endosome acidification inhibitors, bafilomycin A-1 (BFLA-1) and chloroquine, on the mNDK or HXB2 Env-
bearing HIV-1 vector. Transduction titers of the mNDK and HXB2 HIV-1 vectors were measured on 293T (panel A), TE671 (panel B), and HeLa (panel
C) cells treated with the inhibitors. Relative values to the titers on cells treated with an equal volume of DMSO are indicated. Asterisks indicate
statistically significant differences compared to the relative value on the DMSO-treated cells. Cathepsin B activities of cell lysates from the DMSO
(open bar)- or chloroquine (closed bar)-treated cells were measured (panel D left panel). 293T, TE671, and HeLa cells were treated with chloroquine at
25, 50, and 200 mM, respectively. DMSO or chloroquine was added to cell lysates from untreated cells, and their cathepsin B activities were measured
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in this study.
Transduction assay
To obtain HIV-1 vector particles containing the Env protein,
monkey COS7 cells were transfected with a packaging construct of
HIV-1 (R8.91) [58], LacZ-containing HIV-1 vector (pTY-EfnLacZ)
[59], and the appropriate Env expression plasmids (2 mge a c h )u s i n g
t h eF u g e n et r a n s f e c t i o nr e a g e n t( R o c h e ) .T h et r a n s f e c t e dc e l l sw e r e
washed with medium 24 h after transfection, and continued to be
cultured in fresh medium for 24 h. Target cells were pre-treated with
chloroquine (Sigma), bafilomycin A-1 (BFLA1) (Sigma), CA-074Me
(Sigma), or dynasore (Calbiochem, La Jolla, CA) for 5 h. Because
these compoundswere dissolved inDMSO(Sigma),cellsweretreated
with an equal volume of DMSO as a control. The pre-treated cells
were inoculated with the culture supernatants ofthe vector-producing
cells. The inoculated cells were stained with 5-bromo-4-chloro-3-
indolyl-b-D-galactopyranoside (X-Gal) (Wako) 2 days after inocula-
tion. Blue cells were counted to estimate the transduction titer. The
undiluted HIV-1 vector containing the mNDK Env protein induced
(1.0+20.4)610
5,( 5 . 5 +23.1)610
4,( 9 . 2 +24.4)610
4 blue cells in
DMSO-treated 293T/CD4, TE671/CD4, and HeLa/CD4 cells,
respectively. The undiluted mNDK HIV-1 vector induced
(6.0+21.6)610
3,( 2 . 1 +20.5)610
3,a n d( 2 . 1 +20.3)610
2 blue cells in
DMSO-treated 293T, TE671, and HeLa cells, respectively.
Therefore, when the HIV-1 vector was inoculated into CD4-positive
cells, the vector solution was diluted 20-fold to normalize the
transduction titer. The undiluted HIV-1 vector containing the
ROD/B Env protein usually induced (5.3+23.1)610
4 blue cells in
CD4-expressing TE671 cells, and (1.9+21.3)610
4 blue cells in
(panel D right panel). Fluorescence intensities were indicated. The cell surface expression of CXCR4 was analyzed on the treated cells by a
fluorescence flow cytometer (panel E). Relative values to means of fluorescence intensity in the DMSO-treated cells are indicated. This experiment was
repeated 3 times, and the results are shown as averages +2 SD.
doi:10.1371/journal.pone.0019352.g009
Figure 10. Effects of an endocytosis inhibitor, dynasore, on the mNDK Env-bearing HIV-1 vector infection. (A) Transduction titers of the
mNDK HIV-1 vectors were measured on dynasore- or DMSO-treated 293T (left panel), TE671 (middle panel), and HeLa (right panel) cells. Relative
values to the titers on cells treated with an equal volume of DMSO are indicated. (B) The cell surface expression of CXCR4 was analyzed on the treated
cells by a fluorescence flow cytometer. Relative values to means of fluorescence intensity in the DMSO-treated cells are also indicated. (C) Cathepsin B
activities of cell lysates from DMSO- or dynasore-treated cells were measured (left panel). DMSO or dynasore was added to cell lysates from untreated
cells, and their cathepsin B activities were measured (right panel). Fluorescence intensities were indicated. (D) Effects of chloroquine, CA-074Me, and
dynasore on endocytosis of Cy3-conjugated transferin were analyzed. Relative values to means of fluorescence intensity in DMSO-treated cells were
indicated. These experiment were repeated 3 times, and the results are shown as averages +2 SD.
doi:10.1371/journal.pone.0019352.g010
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inoculated into CD4-positive cells, the vector was diluted 3-fold.
DMSO-treatment did not affect these HIV-1 vector infections.
Screening of the cDNA expression library
A cDNA expression library prepared from human lymph nodes
was commercially obtained from TaKaRa (Shiga, Japan). HeLa
cells were transfected with the cDNA expression library (3 mg) by
using Fugene transfection reagent (50 ml), and were selected by
geneticin (Invitrogen). The geneticin-resistant cell pools were
inoculated with the blasticidin resistance gene-encoding mNDK
Env-bearing HIV-1 vector. The HIV-1 vector was constructed by
transfection of COS7 cells with the R8.91 and mNDK Env
expression plasmids together with a blasticidin resistance gene-
encoding HIV-1 vector genome expression plasmid (Invitrogen).
The inoculated cells were selected by blasticidin (Invitrogen).
Blasticidin-resistant cell clones were analyzed in this study. To
amplify the cDNA sequence present in the blasticidin-resistant
HeLa cells, PCR was performed using genomic DNA samples
prepared from the cells. The nucleotide sequences of the PCR
primers (Genenet, Fukuoka, Japan) were 59-TAC GAC TCA CTA
TAG GGA ATT CGA-39 and 59-TGT ATC TTA TCA TGT
CTG GAT CCC-39. Nucleotide sequence of the PCR product was
determined by the Big Dye Terminator Cycle Sequencing Kit
(Applied Biosystems, Warrington, UK). Accession number of the
nucleotide sequence of the PCR product is AB587083.
FACS
To analyze the cell surface expression of CXCR4, suspended
cells were treated with a rat anti-CXCR4 antibody (A80) [60] or
control serum for 1 h at 4uC. The cells were washed with PBS 3
times, and then treated with an FITC-conjugated anti-rat IgG
antibody (Sigma). The stained cells were applied to a flow
cytometer (BD Biosciences, San Jose, CA).
Figure 11. Dominant negative mutant of Eps15 inhibits CD4-independent HIV-1 vector infection, but not CD4-dependent infection.
(A) Transduction titers of the mNDK vector were measured on 293T, TE671, and HeLa cells transfected with an expression plasmid of GFP-tagged
Eps15 dominant negative mutant (Eps15-DN). Relative values to the titers on the pUC18-transfected cells were indicated. (B) The Eps15-DN
expression in the transfected cells was analyzed by measuring fluorescence intensities of the transfected cells, because the Eps15-DN protein was
tagged with GFP. Means of the fluorescence intensities of the transfected cells were indicated. Relative values to means of fluorescence intensity in
the DMSO-treated cells are also indicated. (C) The cell surface expression of CXCR4 was analyzed on the treated cells by a fluorescence flow
cytometer. Relative values to means of fluorescence intensity in the DMSO-treated cells are also indicated. These experiments were repeated 3 times,
and the results are shown as averages +2 SD.
doi:10.1371/journal.pone.0019352.g011
Figure 12. Effects of inhibitors of cathepsin B, endosome acidification, and endocytosis on CD4-independent ROB/B Env-
pseudotyped HIV-1 vector infection. Transduction titers of the ROD/B vector were measured on TE671 and TE671/CD4 cells treated with CA-
074Me (panel A), chloroquine (panel B), or dynasore (panel C). Relative values to the titers on the DMSO-treated cells (Cont.) are indicated. This
experiment was repeated 3 times, and the results are shown as the means +2 SD. Asterisks indicate statistically significant differences compared to
the control cells.
doi:10.1371/journal.pone.0019352.g012
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To measure cathepsin B activity in living cells, cells were stained
with the cathepsin B detection reagent (Cell Technology,
Minneapolis, MN). This reagent utilizes fluorophore cresyl violet
that is bi-substituted by an amide linkage to a peptide that contains
a cathepsin B target cleavage sequence. In this form, the cresyl
violet leaving group is non-fluorescent. Following cleavage at the
amide linkage site by cathepsin B in living cells, the mono and
non-substituted cresyl violet fluorophores generates red fluores-
cence. The stained cells were subjected to a flow cytometer (BD
Biosciences) to measure their fluorescence intensity.
To measure the cathepsin B activity of cell lysates, a cathepsin B
activity assay kit (BioVision, Mountain View, CA) was used. The
cathepsin B activity assay kit is a fluorescence-based assay that
utilizes the preferred cathepsin B substrate amino acid sequence
labeled with amino-4-trifluoromethyl coumarin (AFC). Cell lysates
that contain cathepsin B will cleave the synthetic AFC-labeled
substrate to release free AFC, and generate fluorescence. Cell
lysates were incubated with the cathepsin B substrate of the assay
kit for 1 h at 37uC, and fluorescence intensity at 505 nm was
measured by a fluorescence microplate reader (PerkinElmer,
Turku, Finland).
Western immunoblotting
Cell lysates were subjected to sodium dodecyl sulfate polyacryl-
amide gel electrophoresis (BioRad, Hercules, CA), and were
transferred onto a PVDF membrane (Millipore, Billerica, MA).
The membrane was treated with an anti-cystatin C or anti-actin
antibody (Santa Cruz Biotechnology, Santa Cruz, CA), and then
with a horseradish peroxidase-conjugated protein G (BioRad).
Protein G-bound polypeptides were visualized by ECL Western
blottingdetectionreagents(GEHealthcare,Buckinghamshire,UK).
Semi-quantitative RT-PCR
Total RNA was isolated from cells by using TRIsol reagent
(Invitrogen). First strand cDNA was synthesized from the total
RNA with random hexamers by means of a reverse transcriptase
(TaKaRa). Semi-quantitative PCR was performed using the first
strand cDNA as a template to detect cystatin C, cathepsin B, and
GAPDH mRNAs. The nucleotide sequences of the PCR primers
(Genenet) for the cystatin C mRNA were 59-TCC TAG CCG
ACC ATG GCC-39 and 59-CGG TAC AGA CCC CTA GGC-
39, those for cathepsin B mRNA were 59-GTG TAC CAA CAC
GTC ACC GGA-39 and 59-CAG GCC CAC GGC AGA TTA-39
[19], and those for the GAPDH mRNA were 59-AGG TCG GAG
TCA ACG GAT TTG GT-39 and 59-GTG GGC CAT GAG
GTC CAC CAC-39.
Endocytosis assay
Target cells were pretreated with inhibitors for 4 h, and then
starved in presence of inhibitors for 1 h. Cy3-conjugated transferin
(4 mg/ml) (Jackson Laboratories) was added, and incubated for
10 min. Surface-bound transferin was removed by trypsin
treatment of the cells for 15 min. Fluorescence intensities of the
cells were measured by a flow cytometer (BD Biosciences).
Statistical analysis
Differencesbetweengroups inrelative values were determined by
Student’s t-test. Correlation between relative values of cathepsin B
activities and susceptibilities to the CD4-independent mNDK
vector infection was analyzed by Spearman’s rank correlation.
The level of statistical significance was set at p,0.05 for all tests.
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Figure 13. Infection route of the CD4-dependent (open) or CD4-independent (grey) HIV-1.
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